Atea Pharmaceuticals (AVIR) announced that the full results from the Phase 2 clinical study of Atea’s regimen of bemnifosbuvir, a nucleotide ...

Inflammation is likely a key player in atherosclerosis and related cardiovascular events, but questions remain about its role ...

BACKGROUND: Elevated plasma levels of Lp(a) [lipoprotein(a)] are a causal risk factor for coronary heart disease and stroke ...

Epigenetic "clocks" measure biological age, which predicts earlier or later onset of the leading causes of death. Childhood ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an important role in both ...

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an important role in both the onset and progression of CRC, emerging evidence ...

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an important role in both ...

Colorectal cancer (CRC) is one of the most prevalent cancers worldwide. While scientists believe that gut microbiota play an ...

Evercore is serving as Atea's financial advisor and Latham & Watkins LLP is serving as legal counsel. Olshan Frome Wolosky ...

Atea Pharmaceuticals, Inc.’s AVIR share price has surged by 5.33%, which has investors questioning if this is right time to sell.

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...